← Back
Data updated: Mar 10, 2026
NYLOS
Neurology
NYLOS is a pharmaceutical company focused on Neurology.
-
Since
5
Drugs
-
Trials
53
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PREDNISONE 2025-10-01
METHOCARBAMOL 2025-04-08
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-05
Labeling
PREDNISONE 2024-06-05
Labeling
PREDNISONE 2024-06-05
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (4)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 5